<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:department>Centre for Cancer Res and Cell Biology</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9DF91719-A91E-4994-B6DB-8537EA18740F"><gtr:id>9DF91719-A91E-4994-B6DB-8537EA18740F</gtr:id><gtr:firstName>D</gtr:firstName><gtr:otherNames>Paul</gtr:otherNames><gtr:surname>Harkin</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0200103"><gtr:id>74DE8745-3CA0-4E29-A4A3-EE093A047F65</gtr:id><gtr:title>Role played by BRCA1 in the transcriptional regulation of the interferon and DNA damage response pathways</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0200103</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>598836</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Programme Grant</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>5FCB058A-9AE8-492C-92DC-6902521F1014</gtr:id><gtr:outcomeId>nD2HD6iKYX40</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D8CFD205-B440-4108-BC54-B9C876738040</gtr:id><gtr:title>BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer.</gtr:title><gtr:parentPublicationTitle>Breast cancer research and treatment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c36b222012acb03861b96f398c3518bb"><gtr:id>c36b222012acb03861b96f398c3518bb</gtr:id><gtr:otherNames>Gorski JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0167-6806</gtr:issn><gtr:outcomeId>BB79B21FFA2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>319142B8-12BD-4B35-97CC-9C99527E004D</gtr:id><gtr:title>BRCA1, a potential predictive biomarker in the treatment of breast cancer.</gtr:title><gtr:parentPublicationTitle>The oncologist</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/146488305af3aacb8ade6288f48c2757"><gtr:id>146488305af3aacb8ade6288f48c2757</gtr:id><gtr:otherNames>James CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1083-7159</gtr:issn><gtr:outcomeId>B2544AEEB97</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5E9FEF7-8FFE-4C2C-94DA-F10CAA6366C8</gtr:id><gtr:title>BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cab8d02ffd417e0c298816bce39e56d2"><gtr:id>cab8d02ffd417e0c298816bce39e56d2</gtr:id><gtr:otherNames>Quinn JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn><gtr:outcomeId>B00A5D9C1F9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1CA2606-F2BC-4528-8FB8-5466E14F8EF4</gtr:id><gtr:title>BRCA1 suppresses osteopontin-mediated breast cancer.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a5d0d2dac6c69e3663a1e23a3708bb"><gtr:id>13a5d0d2dac6c69e3663a1e23a3708bb</gtr:id><gtr:otherNames>El-Tanani MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>CF6FE840C66</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C62AA656-AF12-472F-8E6D-E4B80B0DC335</gtr:id><gtr:title>BRCA1 regulates IFN-gamma signaling through a mechanism involving the type I IFNs.</gtr:title><gtr:parentPublicationTitle>Molecular cancer research : MCR</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1bbebd92a0d81ac71a64802f022f792"><gtr:id>e1bbebd92a0d81ac71a64802f022f792</gtr:id><gtr:otherNames>Buckley NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1541-7786</gtr:issn><gtr:outcomeId>1DABF11D6E4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>606A75E9-758A-4558-AA26-90B0ECF6E09D</gtr:id><gtr:title>Genomics and the impact of new technologies on the management of colorectal cancer.</gtr:title><gtr:parentPublicationTitle>The oncologist</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7feb61e0b0a37a17fdda58f854364a7"><gtr:id>f7feb61e0b0a37a17fdda58f854364a7</gtr:id><gtr:otherNames>Harkin DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1083-7159</gtr:issn><gtr:outcomeId>7596ABD44DB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE137EB1-1DD4-4EDD-8B9A-575006653FE6</gtr:id><gtr:title>Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c33c2520f44f104bc153ec98ba14cf47"><gtr:id>c33c2520f44f104bc153ec98ba14cf47</gtr:id><gtr:otherNames>Hill A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>DDAD26B5265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>648444CF-862C-4432-8251-067EB0F0A87D</gtr:id><gtr:title>The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c36b222012acb03861b96f398c3518bb"><gtr:id>c36b222012acb03861b96f398c3518bb</gtr:id><gtr:otherNames>Gorski JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn><gtr:outcomeId>B11A811A9FE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0DFCA3E-9920-4B53-94CB-94B348708322</gtr:id><gtr:title>The role of BRCA1 in transcriptional regulation and cell cycle control.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c6c5df3ce10eba7d6f9513578f1ceb4"><gtr:id>1c6c5df3ce10eba7d6f9513578f1ceb4</gtr:id><gtr:otherNames>Mullan PB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>D2446B6B12F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94A8CB9C-BBB3-4BE3-AE9B-F0005DDC0D04</gtr:id><gtr:title>Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.</gtr:title><gtr:parentPublicationTitle>Journal of the National Cancer Institute</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/095603491fb29ae7c09ea9cb92bcea46"><gtr:id>095603491fb29ae7c09ea9cb92bcea46</gtr:id><gtr:otherNames>Hosey AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8874</gtr:issn><gtr:outcomeId>0657B9DF259</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1E3F16E-218A-4EB5-9020-F84D3AB77D81</gtr:id><gtr:title>Role played by BRCA1 in transcriptional regulation in response to therapy.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a00bac5593262f79c645c07f31e1636a"><gtr:id>a00bac5593262f79c645c07f31e1636a</gtr:id><gtr:otherNames>Murray MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>88396B6F7AB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76BD5FCB-9160-46B6-8301-52474FEFD29B</gtr:id><gtr:title>BRCA1 and implications for response to chemotherapy in ovarian cancer.</gtr:title><gtr:parentPublicationTitle>Gynecologic oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cab8d02ffd417e0c298816bce39e56d2"><gtr:id>cab8d02ffd417e0c298816bce39e56d2</gtr:id><gtr:otherNames>Quinn JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0090-8258</gtr:issn><gtr:outcomeId>9A658401203</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55218358-54BE-443C-BEF6-D91915E16417</gtr:id><gtr:title>BRCA1--a good predictive marker of drug sensitivity in breast cancer treatment?</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c6c5df3ce10eba7d6f9513578f1ceb4"><gtr:id>1c6c5df3ce10eba7d6f9513578f1ceb4</gtr:id><gtr:otherNames>Mullan PB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>252D02BA41A</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0200103</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>